Lilly completes acquisition of immuno-oncology firm Armo BioSciences
Strategic Expansion in Cancer Treatment: Eli Lilly and Company (Lilly), a leading US pharmaceutical firm, has finalized its acquisition of Armo BioSciences, a California-based immuno-oncology ... Read More
Merck to acquire Australian biotech firm Viralytics for $394m to bolster oncolytic immunotherapy treatments
Significant Acquisition in Pharma Industry: US pharmaceutical giant Merck has announced a definitive agreement to acquire Viralytics, an Australian biotech company, for AUD 502 million ... Read More
India’s CDSCO grants APAC Biotech license for immuno-oncology drug Apceden
The Central Drugs Standard Control Organization (CDSCO), India's regulatory authority, has granted a commercial license to APAC Biotech for the marketing of Apceden, a Dendritic ... Read More